semaglutide levocarnitine compound | C187H291N45O59 | CID 56843331 Compounded Semaglutide – $149/mo |
Description
BMI (Body Mass Index): A simple ratio of weight to height used to classify underweight, normal, overweight, or obesity
This includes both the drugs covered and the out-of-pocket costs
The strengths are real
The combination of GLP-1 and GIP creates dual action, which promotes greater weight loss and metabolic improvements as compared to other GLP-1 weight loss drugs such as semaglutide (Wegovy)
This improved insulin sensitivity can reduce liver fat and circulating free fatty acids, which aids metabolic function without massive changes in silhouette
